Volume : 7, Issue : 9, SEP 2021




Cerebral palsy (CP) is primarily a neuromotor disorder that affects the development of movement, muscle tone and posture. The underlying pathophysiology is an injury to the developing brain in the prenatal through neonatal period. Although the initial neuropathologic lesion is non-progressive, children with CP may develop a range of secondary conditions over time that wills variably affect their functional abilities.1 Hemiplegia in Infants and children is a type of cerebral palsy that results from damage to the part of hemisphere of the brain that controls muscle movements. This damage may occur before, during or shortly afterbirth.2 The aim of study is to compare the effects of CONSTRAINT INDUCED MOVEMENT THERAPY and NEURODEVELOPMENT THERAPY in patients with Hemiplegic cerebral palsy. It’s a comparative study with 30 subjects was requited with hemiplegic CP. Result illustrates comparison between age of Group A & B. It was found that mean & standard deviation of age in Group A is 8.60 ± 4.067 & for Group B 7.93 ± 3.730 with mean difference of 0.67, with p value p= 0.6436 which is not significant. The groups for Upper Extremity functional Index for Pre mean & S.D for Group A & Group B was 29.00±14.041 & 42.73±18.215 & post mean & SD for Group A & Group B was 40.33±12.882 & 52.87±14.232. Pre & Post mean difference for Upper Extremity Functional Index for both the group was 13.73 & 12.53 & p value was p= 0.028 & p= 0.01 which is significant. Conclusion The study shows that constraint induced movement therapy & neuro developmental therapy improves upper extremity functions & tone, but spastically constraint induced movement therapy give more significantly improvement motor function & tone in Hemiplegic CP.


Article : Download PDF

Cite This Article

Article No : 6

Number of Downloads : 76


  1. "Cerebral Palsy: Hope through Research". National Institute of Neurological Disorders and Stroke July 2013eArchived from the original on 21 February 2017. Retrieved 21 February 2017.
  2. Oskoui, M; Coutinho, F; Dykeman, J; Jetté, N; Pringsheim, T (June 2013). "An update on the prevalence of cerebral palsy: a systematic review    and meta-analysis". Developmental Medicine & Child Neurology. 55(6): 509–19. Doi:10.1111/dmcn.12080. PMID 23346889. S2CID 22053074.
  3. Haak Peterson; Lenki Madeleine (October 2009) Haak, Developmental Medicine & Child Neurology. 51:16–23. PMC 4183123. PMID 19740206.
  4. "Cerebral Palsy: Overview". National Institutes of Health. Archived from the originalon 15 February 2017. Retrieved 21 February 2017.
  5. "CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 1; CPSQ1". Online Mendelian Inheritance in Man. 28 June 2016. Retrieved 26 January 2018.
  6. Rosenbaum, P. (February 2007). "A report: the definition and classification of cerebral palsy April 2006". Developmental Medicine & Child Neurology. 49: 8–14.
  7. Farag, Sara M.; Mohammed, Manal O.; EL-Sobky, Tamer A.; ElKadery, Nadia A.;ElZohiery, Abeer K. (March 2020). "Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials". JBJS Reviews. 8 (3): e0119.
  8. Blumetti Francesco C; Belloti Carlos ( 8 October 2019) "Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy". Cochrane Databaseof Systematic Reviews. 10: CD001408. doi:10.1002/14651858.CD001408.pub2
  9. How many people are affected?". National Institutes of Health. 5 September 2014.Archived from the original on 2 April 2015. Retrieved 4 March 2015.
  10. Panteliadis, C; Panteliadis, P; Vassilyadi, F(April 2013)."Hallmarks in the history ofcerebral palsy: from antiquity to mid-20th century". Brain & Development. 35 (4): 285–92.
  11. "What is cerebral palsy?". The Cerebral Palsied Association of the Philippines Inc. Archived from the original on 20 December 2016. Retrieved 4 December 2016.
  12. Rosenbaum, P; Paneth, N; Leviton, A; Goldstein, M; Bax, M; Damiano, D; Dan, B;Jacobsson, B (2007). "A report: The definition and classification of cerebral palsy April 2006". Developmental Medicine & Child Neurology. 49 (s109): 8–14.
  13. Kent R (2013). "Chapter 38: Cerebral Palsy". In Barnes MP, Good DC (Eds.). Handbook of Clinical Neurology. 3. 110. Elsevier. pp. 443–459. ISBN 978-0444529015.
  14. Ajaya K. Sah, Gandhi Karunanithi Balaji, and Sahana Agrahara: Effect of Task Oriented Activity Based on Neurodevelopment Therapy Principle on Trunk Control, Balance, Gross Motor Function in Children with Spastic diplegic Cerebral Palsy; J Pediatr Neurosci. 2019 Jul-Sep; 14(3): 120–126.
  15. Thomas Besios, Aggelousis Nikolaos, Gourgolis Vassilios et al; Effect of the NDT on the mobility of children with Cerebral Palsy; Open Journal of Therapy & Rehabilitation Vol.6 No:4; Nov 2018. 95-103.
  16. Eun Young Park, Won- Ho Kim, Effect of Neruo Development Treatment based physical therapy on the change of muscle strength, spasticity & gross motor function in children with spastic Cerebral Palsy: J. Phys. Ther. Sci: 29:966-969, 2017.
  17. Sina Labof et al. effect of NDT in Gross Motor Function in Children with CP Irani Journal of child neurology spring 2015 , 9 (1) : 36-241
  18. Marise Bueno Zonta, Isac Bruck et al effect of Early Spasticity treatment children with Hemiplegic C.P: A preliminary Study, Arq Neuro – Psiquiatr Vol 71 No 7 Paulo July 2013.
  19. Ann christin Eliassan , Lena Krumlinde: Guidelines for future research in Constraint Induced Movement Therapy for children with unilateral developmental medicine & child neurology July 2013 ; d01:10.11 11dmcn :1227
  20. Shoko Yoshida, Andreia V. Faria, Kanichi Oishi; Anatomical Characterization of athetoid & spastic cerebral palsy using atlas- based analysis; JMRI; Vol.38, Issue 2, August 2013; 288-298.
  21. Deluca, K Smith. Pediatric Constraint Induced Movement Therapy: Handbook of pediatric CIMT: A Guide to OTS allied health care, chapter-2 page no 1-19
  22. Roslyn Boyd, Leanne Sakzewski et al; A randomaized trial comparing constraint induced movement therapy & bimanual training in children with congenital hemiplegia; BMC Neurology; 2010; 10:4.
  23. Brain J Hoare et al modified constraint induced movement therapy followings injection of Botulinum toxin –A to improve bimanual performance in young children with Cerebral Palsy: Randomized controlled trail; BMC Neurology 2010 10:58.
  24. Leanne Sakzewski, Jenny Ziviani et al’ Systemic Review & Meta- Analysis of Theraputic Management of Upper Limb Dysfunction in Children with Congenital Hemiplegia; Pediatrics: 2009 Jun; 123 (6): 1111-22.
  25. Beatrice Bonnier, Ann – Christen Eliassan Effect of CIMT in adolescents Hemiplegic Cerebral Palsy: Aday Camp model; Scandinavian journal of occupational Therapy; 2006; 13:13-22.
  26. Andrew M Jordon, Jeanne Charles et al: Efficacy of Constraint Induced Movement Therapy on involved upper Extremity use in children with Hemiplegic Cerebral Palsy is not Age Dependent; Pediatrics Vol. 117, No-3 March 2006.
  27. Saleh AL- Oraibi, Ann- Christin Eliasan; Implementation of Constraint Induced Movement Therapy for young children with unilateral Cerebral Palsy in Jordan: a home based model; Disabil Rehabil: 2006; 33 (21-22) 2006-2012.
  28. Akmer Mutlu, Ayse Livanelioglu, and Mintaze Kerem Gunel, Reliability of Ashworth and Modified Ashworth Scales in Children with Spastic Cerebral Palsy, BMC Musculoskeletal Disord 2006, 9:44.
  29. Hamid Abolhasani, Noureddin Nakhostin Ansari, Comparing the Validity of Modified Ashworth Scale and modified tardieu scale in assessment of wrist flexor spasticity in patients with stroke, 2005, BMJ Open 2012;2.
  30. Bert M. Chesworth, BA, BScPT, MClScPT, PhD, Clayon B. Hamilton, MSc Reliability and Validity of Two Versions of the Upper Extremity Functional Index Physiotherapy Canada 2005; 66(3);243–253; doi:10.3138/ptc.2013-45.
  31. Jeanne R Charles, Steven L Wolf et al; Efficacy of child friendly form of Constraint Induced Movement Therapy in hemiplegic Cerebral palsy: A randomized controlled trial, Developmental Medicine and Child Neurology 2006, 48:635-642.